Archives
-
S. eriocheiris Entry into Drosophila S2 Cells
2026-08-26
Wei and colleagues established a Drosophila Schneider 2 cell model to show that Spiroplasma eriocheiris invades invertebrate cells through clathrin-mediated endocytosis and macropinocytosis. Pharmacological perturbation and cytoskeletal studies connect bacterial internalization with clathrin, macropinocytic signaling, actin, and microtubule function, while also revealing infection-associated oxidative stress and cell damage.
-
DAT PET Tracks Dopaminergic Neuron Maturation
2026-08-26
Goggi et al. showed that longitudinal dopamine transporter PET can assess the survival, maturation, and presynaptic integration of transplanted human embryonic stem cell-derived midbrain dopaminergic neurons in a rat model of Parkinson’s disease. The study demonstrates why imaging should be interpreted alongside behavioral and histological endpoints when evaluating cell-replacement therapies.
-
PPM-18: Reading iNOS Signals in Redox Assays
2026-08-25
PPM-18 is an iNOS expression inhibitor that helps separate NF-κB-driven inflammatory transcription from broader redox signaling. This article uses cardiac redox biology to develop a more rigorous framework for assay design, controls, and interpretation in inflammation and sepsis research.
-
Cuproptosis Signatures for Glioma Treatment
2026-08-25
The reference study developed a cuproptosis-related gene signature to classify gliomas by copper-homeostatic state, clinical risk, and potential sensitivity to elesclomol. Its integrated transcriptomic, clinical, and experimental strategy links worsening glioma grade with copper dysregulation and provides a framework for testing copper-dependent treatment hypotheses.
-
S Tag Peptide: Fusion Tag Workflow Guide
2026-08-24
S Tag Peptide is a short, highly soluble RNase A-derived tag used to support recombinant protein detection, antibody-based capture, and protein solubility improvement. It is suitable for aqueous expression and purification workflows but should not be treated as an independently active ribonuclease reagent or prepared in ethanol.
-
Plerixafor (AMD3100): A Translational CXCR4 Strategy
2026-08-24
Plerixafor (AMD3100) is more than a CXCR4 inhibitor: it is a mechanistic probe for tumor migration, hematopoietic stem cell mobilization, and immune-cell trafficking. This thought-leadership guide places the compound alongside emerging CXCR4 antagonist A1 and provides a practical framework for translating pathway biology into reproducible research decisions.
-
RNA Pol II Loss Triggers Apoptosis Beyond Transcription
2026-08-23
Harper et al. show that RNA polymerase II inhibition can kill cells through an active apoptotic response rather than through passive loss of transcription, mRNA, and protein. Their work identifies degradation of hypophosphorylated RNA Pol IIA as the initiating signal and provides a framework for interpreting the cytotoxicity of diverse transcription-targeting therapies.
-
Adipose-Neural Signaling in Cardiac Arrhythmia
2026-08-22
Fan et al. developed a stem cell-based coculture model showing how epicardial adipose tissue can communicate with sympathetic neurons and cardiomyocytes through a leptin–NPY–Y1R pathway. The study connects this signaling axis to NCX and CaMKII activity and supports its clinical relevance through measurements in patients with atrial fibrillation.
-
Electrical Stimulation Boosts Nanoparticle Uptake
2026-08-22
The reference study shows that alternating-current electrical stimulation increases magnetic nanoparticle endocytosis in several cancer cell types, primarily through macropinocytosis associated with altered F-actin and intracellular Ca2+ levels. The approach also improves magnetic-hyperthermia cytotoxicity and MRI signal intensity, suggesting a broadly applicable physical strategy for enhancing nanoparticle-based cancer workflows.
-
Hesperadin: Aurora B Kinase Inhibitor Guide
2026-08-21
Hesperadin is an ATP-competitive Aurora B kinase inhibitor used to interrogate mitotic progression, chromosome segregation, and spindle assembly checkpoint biology. Its biochemical and HeLa-cell benchmarks support mechanistic cell-cycle research, but they do not establish clinical efficacy or complete kinase selectivity.
-
Novel PDK4 Inhibitors for Metabolic Disease
2026-08-20
The reference study converted an anthraquinone hit into a new series of allosteric pyruvate dehydrogenase kinase 4 inhibitors and identified compound 8c as a potent lead. Its activity across biochemical, pharmacokinetic, metabolic, allergic, and cancer-related models supports PDK4 as a tractable drug-discovery target, while also highlighting the gap between promising preclinical evidence and clinical translation.
-
Bazedoxifene: From SERM Biology to Translation
2026-08-20
Bazedoxifene offers translational researchers a disciplined way to study tissue-selective estrogen receptor biology, linking receptor engagement with bone outcomes while defining the limits of extrapolation into oncology and clinical development.
-
Indometacin Enhances Endogenous Remyelination
2026-08-19
The reference study shows that indometacin can promote oligodendrocyte differentiation, tissue myelination, and remyelination in experimental models, extending the role of an established NSAID beyond inflammation control. Its mechanistic experiments connect this effect to GSK3β activity and β-catenin phosphorylation, providing a rationale for investigating repair-oriented strategies in multiple sclerosis.
-
DOTAP: Cationic Lipid for Nucleic Acid Delivery
2026-08-19
1,2-Dioleoyl-3-trimethylammonium-propane chloride, also called DOTAP, is a synthetic cationic lipid for DNA, RNA, and antisense oligonucleotide delivery. Its electrostatic complexation and formulation flexibility support transient gene expression, functional genomics, and lipid nanoparticle optimization, but performance remains formulation- and cell-type-dependent.
-
Naloxone Hydrochloride: A Translational Playbook
2026-08-18
Naloxone hydrochloride is more than a canonical opioid receptor antagonist. This thought-leadership guide shows how to use its receptor-dependent, receptor-independent, immune, and behavioral biology to design stronger translational studies while avoiding overinterpretation across research domains.